|
1
|
Califano R, Karamouzis MV, Banerjee S, de
Azambuja E, Guarneri V, Hutka M, Jordan K, Kamposioras K,
Martinelli E, Corral J, et al: Use of adjuvant chemotherapy (CT)
and radiotherapy (RT) in incompletely resected (R1) early stage
non-small cell lung cancer (NSCLC): A European survey conducted by
the European society for medical oncology (ESMO) young oncologists
committee. Lung Cancer. 85:74–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stewart DJ: Mechanisms of resistance to
cisplatin and carboplatin. Crit Rev Oncol Hematol. 63:12–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chin LS, Park CC, Zitnay KM, Sinha M,
DiPatri AJ Jr, Perillán P and Simard JM: 4-Aminopyridine causes
apoptosis and blocks an outward rectifier K+ channel in malignant
astrocytoma cell lines. J Neurosci Res. 48:122–127. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim JA, Kang YS, Jung MW, Kang GH, Lee SH
and Lee YS: Ca2+ influx mediates apoptosis induced by
4-aminopyridine, a K+ channel blocker, in HepG2 human
hepatoblastoma cells. Pharmacology. 60:74–81. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang W, Xiao J, Adachi M, Liu Z and Zhou
J: 4-aminopyridine induces apoptosis of human acute myeloid
leukemia cells via increasing [Ca2+]i through P2X7 receptor
pathway. Cell Physiol Biochem. 28:199–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang L, Li B, Li W, Guo H and Zou F:
ATP-sensitive potassium channels control glioma cells proliferation
by regulating ERK activity. Carcinogenesis. 30:737–744. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai T, Zhou Q, Zeng X, He J, Yang Y, Li C,
Ren D, Liu L and Liao B: A study on the characteristics of the
membrane potassium channels in human non-small cell lung cancer
cell. Zhongguo Fei Ai Za Zhi. 4:281–286. 2001.(In Chinese).
PubMed/NCBI
|
|
9
|
Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S,
Long X, Jiang Q, Song Y, Cheng C, et al: Tumor suppressor PDCD4
modulates miR-184-mediated direct suppression of C-MYC and BCL2
blocking cell growth and survival in nasopharyngeal carcinoma. Cell
Death Dis. 4:e8722013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ru Q, Tian X, Wu YX, Wu RH, Pi MS and Li
CY: Voltage-gated and ATP-sensitive K+ channels are associated with
cell proliferation and tumorigenesis of human glioma. Oncol Rep.
31:842–848. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y,
Zhang Y, Hua S, Fu Q, Zhao M, et al: Downregulation of FAP
suppresses cell proliferation and metastasis through PTEN/PI3K/AKT
and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death
Dis. 5:e11552014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang L, Wang HY, Li JD, Wang JH, Zhou Y,
Luo RZ, Yun JP, Zhang Y, Jia WH and Zheng M: KPNA2 promotes cell
proliferation and tumorigenicity in epithelial ovarian carcinoma
through upregulation of c-Myc and downregulation of FOXO3a. Cell
Death Dis. 4:e7452013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace
AM, Infante AS, Doi S, Santella RM and Weinstein IB: Overexpression
of cyclin D1 in rat fibroblasts causes abnormalities in growth
control, cell cycle progression and gene expression. Oncogene.
8:3447–3457. 1993.PubMed/NCBI
|
|
14
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kroemer G, El-Deiry WS, Golstein P, Peter
ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni
W, Knight RA, et al: Classification of cell death: Recommendations
of the nomenclature committee on cell death. Cell Death Differ. 12
Suppl 2:S1463–S1467. 2005. View Article : Google Scholar
|
|
16
|
Galluzzi L, Maiuri MC, Vitale I, Zischka
H, Castedo M, Zitvogel L and Kroemer G: Cell death modalities:
Classification and pathophysiological implications. Cell Death
Differ. 14:1237–1243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi Y: Mechanisms of caspase activation
and inhibition during apoptosis. Mol Cell. 9:459–470. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong-Dong L, Xi-Ran Z and Xiang-Rong C:
Expression and significance of new tumor suppressor gene PTEN in
primary liver cancer. J Cell Mol Med. 7:67–71. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo H, Yang Y, Duan J, Wu P, Jiang Q and
Xu C: PTEN-regulated AKT/FoxO3a/Bim signaling contributes to
reactive oxygen species-mediated apoptosis in selenite-treated
colorectal cancer cells. Cell Death Dis. 4:e4812013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Florea AM and Büsselberg D: Cisplatin as
an anti-tumor drug: Cellular mechanisms of activity, drug
resistance and induced side effects. Cancers (Basel). 3:1351–1371.
2011. View Article : Google Scholar : PubMed/NCBI
|
